Tuesday, May 7, 2019

ASCO to Tackle Rural Cancer Care Disparity


An accomplished researcher, Dr. Anna Beryozkina serves as an associate clinical scientist with Genentech in San Francisco, California. In her role, she reviews and analyzes data gathered from clinical trials of drugs used to treat rheumatoid arthritis and cancer. Outside of this work, Dr. Anna Beryozkina belongs to the American Society of Clinical Oncology (ASCO).

Beginning in the fall of 2018, ASCO began exploring ways to address the ongoing cancer care disparity between urban and rural patients. Specifically, those who live in rural areas experience worse outcomes and are diagnosed with cancer at a higher rate than those living in urban settings. To that end, ASCO officially announced the launch of the Rural Cancer Care Task Force in April 2019 to begin the work of finding ways to close these care gaps. 

The organization has identified four major pathways the Rural Cancer Care Task Force plans to focus on: provider education/training, workforce recruitment/growth, expansion of telehealth care, and support of relevant research. 

In her comments, ASCO President Monica Bertagnolli, MD, FACS, FASCO, acknowledged that a patient’s home location plays a major role in their chance of beating cancer, and changing that is the fundamental work that the task force will address. For more information about the Rural Cancer Care Task Force and other efforts by ASCO to address disparate care, visit asco.org.

Thursday, March 28, 2019

ACR Urges Congress to Set Aside DoD Funds for Arthritis Research


Tuesday, February 19, 2019

The 2019 EULAR Congress